The increased area under the curve for glucose and insulin suggests glucose intolerance alongside insulin resistance as a result of overfeeding
What changes is your perception of hunger and your caloric intake, not your aerobic or anaerobic threshold
Risk factor screening and prediction modeling of gastrointestinal adverse reactions caused by GLP-1RAs
Potential new therapeutic target for alzheimers disease: Glucagon-like peptide-1
3 Among firms with 5,000 or more workers, coverage had increased to 43% up from 28% the year prior but many of those employers reported that utilization was higher than expected and that covering the medications had a significant impact on 3 Several firms that initially offered coverage had since restricted it to employees with specific medical indications, such as type 2 diabetes, with some noting the challenge of removing a benefit that employees had come to rely on
For some patients, a step-down option to a lower-burden oral GLP-1 is useful, either short-term to bridge the transition, or as a lighter form of long-term support if and when it is clinically appropriate